Restructuring Expenses

3 Months Ended

Mar. 31, 2020

Restructuring and Related Activities [Abstract]

Restructuring Expenses

RESTRUCTURING EXPENSES

In February 2019, we completed a restructuring to combine our women’s health and maternal health sales forces into one integrated sales team, which promotes Intrarosa, the Makena auto-injector and Vyleesi. Approximately 110 employees were displaced through this workforce reduction. We recorded one-time restructuring charges of $7.4 million primarily related to severance and related benefits on our condensed consolidated statement of operations during the first quarter of 2019. The remaining accrued restructuring charges incurred under this program will be paid in cash by the end of the first quarter of 2021.

The following table displays a rollforward of the changes to the accrued balances as of March 31, 2020 (in thousands): 

	Workforce reduction		Contract termination		Other		Total
Balance accrued at December 31, 2019	$	797	$	—	$	—	$	797
Payments	(329)		—		—		(329)
Balance accrued at March 31, 2020	$	468	$	—	$	—	$	468